Search results
AstraZeneca endometrial cancer treatment recommended for EU approval
ShareCast· 6 days agoAstraZeneca announced on Monday that ‘Imfinzi’, or durvalumab, and ‘Lynparza’, or olaparib, have...
TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form
Morningstar· 2 days ago(Alliance News) - AstraZeneca PLC on Friday announced that its medication osimertinib, alongside ...
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
Zacks via Yahoo Finance UK· 5 days agoThe CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary...
Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Simply Wall St. via Yahoo Finance UK· 2 days agoGenerally speaking the aim of active stock picking is to find companies that provide returns that...
AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Zacks via Yahoo Finance UK· 2 days agoThe European Commission approves AstraZeneca's (AZN) Tagrisso in combination with chemotherapy for...
AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Reuters· 7 days ago, opens new tab said on Monday that the European Union drug regulator has accepted a market...
Aptamer Group up 12% on AstraZeneca collaboration
Proactive Financial News· 5 days agoShares of Aptamer Group PLC (AIM:APTA) were up 12% after announcing a new collaboration with AstraZeneca PLC (LSE:AZN) to explore the use of Optimer...
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines...
Benzinga via Yahoo Finance UK· 6 days agoThe European Medicines Agency (EMA) has accepted AstraZeneca Plc's (NASDAQ:AZN) marketing...
UK less ready for next pandemic than before Covid – Oxford vaccinologist
CityAM via Yahoo Finance UK· 4 days agoThe UK's state apparatus is less prepared to deal with a pandemic today than it was before Covid,...
Inhaler start-up bolsters board with pharma experience
Business Insider via Yahoo News UK· 4 days agoJane Gaddum, formerly vice president for emerging brands for AstraZeneca, has joined as chair and...